Ranbaxy puts biosimilars into gear
(Reuters) - Ranbaxy Laboratories Ltd will launch at least three copies of biotech medicines in India by 2015, mostly to treat cancer, and needs to develop such high-tech drugs to remain a serious player in the global generics business, Chief Executive Arun Sawhney said on Tuesday. Sawhney said that Ranbaxy, majority-owned by Japanese drugmaker Daiichi Sankyo, will introduce a "biosimilar" cancer treatment in India next year and follow up with at least two other biosimilars in the same market over the following year or two. ...
Source: news.yahoo.com
No comments:
Post a Comment